Mainstay Medical’s Chronic Low Back Pain Device Approved Post author:Sam Post published:June 22, 2020 Post category:Devices & Diagnostics Letter The company plans to launch the product in the first half of 2021. Source: Devices & Diagnostics Letter You Might Also Like U.S. to Pay Nearly $2 Billion for Pfizer-BioNTech COVID-19 Vaccine July 22, 2020 Valneva and Dynavax Collaborate to Develop COVID-19 Vaccine April 23, 2020 EU, CureVac Near Advanced Purchase Agreement for COVID-19 Vaccine August 20, 2020